Regeneron @Regeneron Twitter profile

Last Seen Profiles

@janrezab

@JotaInfo

@nick_hakim

@itsreallyzyder

@lysmarieetv

@dapo_x

@kayinaru

@geartahna1

@ItsFapping

@corgiloverse

@Vetrikumaran7

@lettice_Mitsuki

@kunelgaur

@ZenZeroTTV

@BobbyMcKBlack

@kamiya_shunichi

@JerryAlberson

@lena_step1

@cucarecheto

@YGEoRammoW3bPdb

@YuriKurashima

@Tamedamus

@WheatDraws

@janfrodeno

@cinematicsaint

@JustTerrifying

@rkid72

@gareth_lane

@TempleDietitian

@kida_bisco

@VoiceActingClub

@knoxrob1

@BGYO_Mikki

@Tomasz_Walczak

@TheoKaiMarlow

@mengitune

Regeneron

@Regeneron

4 years

Update on our #COVID19 novel antibody program: We’ve identified hundreds of virus-neutralizing antibodies from our VelocImmune technology and are now selecting the top candidates for clinical testing. Learn more:

13

247

894

Regeneron

@Regeneron

4 years

@SanofiGenzyme Introducing @SupportEczema , @eczemaresearch , @DianaAward , Atopika and Jamii Light Up, the recipients of the ‘Agents of Change’ #atopicdermatitis (AD) Challenge grants, whose projects will help break the stigma of AD around the world. CC: @sanofi

1

35

564

Regeneron

@Regeneron

6 years

In rheumatoid #arthritis , chronically elevated IL-6 levels may drive inflammation & joint destruction. #ACR17

28

229

487

Regeneron

@Regeneron

4 years

We’re proud to help @NYGOV & @NYGovCuomo fight #COVID19 in a variety of ways, including thru our #RegeneronIOPS team making & donating Viral Transport Media for testing kits

25

68

502

Regeneron

@Regeneron

7 years

80% of RA patients reported spending more time w/ loved ones thanks to treatment, based on our international survey.

9

137

483

Regeneron

@Regeneron

4 years

How do we combat bullying in the #AtopicDermatitis (AD) community? ‘Agents of Change’ AD Challenge steering committee member Africa Luca de Tena Smith says creativity is key. Learn more about the initiative and the 2019 grant recipients at . CC: @Sanofi

0

27

422

Regeneron

@Regeneron

4 years

Our statement on the White House compassionate use request for our investigational monoclonal antibody cocktail:

87

205

382

Regeneron

@Regeneron

3 years

The FDA has issued an Emergency Use Authorization for our investigational antibody cocktail to treat mild to moderate #COVID19 in certain high-risk patients 12 years and older. Learn more:

26

133

309

Regeneron

@Regeneron

7 years

With @SanofiGenzyme , we're sharing the results from our #HonestlyRA US patient survey. Learn more:

17

135

287

Regeneron

@Regeneron

7 years

Our #HonestlyRA international survey found that RA patients wish their treatments worked more effectively.

14

77

310

Regeneron

@Regeneron

7 years

Have you heard about the patients’ insights from our #HonestlyRA US survey? Learn more at: #ArthritisAwarenessMonth

31

156

281

Regeneron

@Regeneron

4 years

1) A lot of you are just getting to know #Regeneron – welcome, and perhaps it’s time to clear a few things up… (thread)

19

102

260

Regeneron

@Regeneron

6 years

The cytokine IL-6 helps keep the immune system in balance between active inflammation and relative calm. #ACR17

8

94

241

Regeneron

@Regeneron

6 years

Follow us as we explore the role of the IL-6 cytokine (a signaling protein) in rheumatoid #arthritis at #ACR17 .

7

70

231

Regeneron

@Regeneron

3 years

Congrats @pfizer & @BioNTech_Group on their #COVID19 vaccine data announced today. We applaud this important scientific progress, as we all work tirelessly to combat this unprecedented pandemic.

2

19

223

Regeneron

@Regeneron

4 years

Announcing positive data from 524 additional non-hospitalized #COVID19 patients in ongoing P2/3 study of Regeneron’s investigational antibody cocktail:

9

103

202

Regeneron

@Regeneron

3 years

@TimOBrien Hi @TimOBrien - please know that the U.S. government has made our investigational antibody cocktail for #COVID19 available for free to patients who qualify under Emergency Use Authorization parameters (just like the vaccines are). More info here:

Regeneron

@Regeneron

3 years

8) After all the hard work, the most important message we want to share is to please get vaccinated – but if you get sick and qualify under the FDA’s emergency authorization, then get TREATED. Find sites here:

8

29

57

14

67

199

Regeneron

@Regeneron

3 years

#ASCO2021 is expected to provide new insights on advanced #NonSmallCellLungCancer ( #NSCLC ). When it comes to the latest research, which of the below topics interests you the most?

Brain mets patients

271

Quality of life

495

13

20

184

Regeneron

@Regeneron

4 years

Early data now available on Regeneron’s antibody cocktail in non-hospitalized COVID-19 patients. Read more:

11

127

181

Regeneron

@Regeneron

4 years

Regeneron’s statement on Emergency Use Authorization request for REGN-COV2, investigational antibody cocktail for COVID-19:

40

70

163

Regeneron

@Regeneron

7 years

DYK: 100% of our drug candidates are invented & developed in-house.

6

65

159

Regeneron

@Regeneron

4 years

#COVID19 program update: We have moved our top SARS-CoV-2-neutralizing antibodies into preclinical- and clinical-scale cell production lines & remain on track to have supply available for clinical studies in June. Read on:

5

75

173

Regeneron

@Regeneron

2 years

#Multiplemyeloma predominantly affects older individuals, so understanding comorbidities to optimally manage the disease is critical. This #ASCO22 we are sharing real-world findings on the prevalence of ocular comorbidities in patients with MM. Learn more:

Search ASCO Abstract 8038

asco.org

2

27

154

Regeneron

@Regeneron

7 years

Continue the open conversation about rheumatoid #arthritis by sharing our #HonestlyRA survey results.

10

85

155

Regeneron

@Regeneron

3 years

Today at #ASH20 , we’re sharing updated data from our investigational bispecific #antibody in #MultipleMyeloma . Learn more:

1

9

146

Regeneron

@Regeneron

2 years

We are continuing our research with bispecific antibodies. Learn more about our ongoing clinical trial evaluating our investigational bispecific antibody in patients with metastatic castration resistant prostate cancer:

Search ASCO Abstract TPS5105

asco.org

3

22

143

Regeneron

@Regeneron

7 years

What if scientists were reality stars … starting this Sunday? Don’t miss #RegeneronSTS finalists on Facebook Live:

1

41

125

Regeneron

@Regeneron

7 years

We presented new data in advanced CSCC today at #ASCO17 #SkinCancer

2

30

128

Regeneron

@Regeneron

2 years

Despite increasing advancements in #MultipleMyeloma research, available therapeutic options can lead to high healthcare costs and poor outcomes for patients. We’re presenting data on real-world outcomes in RRMM at #ASCO22 . Learn more:

Search ASCO Abstract e20011

asco.org

1

30

126

Regeneron

@Regeneron

3 years

#Breaking : We’re reporting positive interim data for our investigational antibody cocktail as a “passive vaccine” to prevent #COVID19 . For more:

2

57

136

Regeneron

@Regeneron

4 years

For ongoing updates on our #COVID19 response efforts, visit:

18

33

122

Regeneron

@Regeneron

7 years

This US #ArthritisAwarenessMonth , we'll be sharing #HonestlyRA US insights about living w/ rheumatoid #arthritis .

2

67

117

Regeneron

@Regeneron

7 years

From a small village in Turkey to IO at Regeneron, meet this Actual Living Scientist:

1

34

104

Regeneron

@Regeneron

5 years

Type 2 inflammation is a potential link between conditions such as #asthma , #foodallergies and #atopicdermatitis . Learn more.

5

16

106

Regeneron

@Regeneron

5 years

New #RegeneronPerspectives : Niall O’Leary, VP and Site Head of IOPS in Ireland, discusses the importance of fostering an environment that is focused on shared values between the U.S. and Ireland teams.

6

20

122

Regeneron

@Regeneron

3 years

Joining the #ASH20 virtual meeting? Don’t miss updates on our investigational bispecifics for #BloodCancer , including new data in #MultipleMyeloma and #NonHodgkinLymphoma .

2

4

108

Regeneron

@Regeneron

4 years

We have initiated a Phase 3 prevention trial for our investigational #COVID19 dual-antibody medicine in collaboration with @NIAIDNews (a part of @NIH ). Read more:

6

68

114

Regeneron

@Regeneron

4 years

Today, we announce the initiation of clinical trials for our investigational anti-viral antibody cocktail for the treatment and prevention of COVID-19:

2

50

113

Regeneron

@Regeneron

4 years

#Breaking : The FDA has approved our novel anti-viral #antibody medicine for Zaire ebolavirus in adult and pediatric patients. #Ebola Read the full announcement:

5

35

107

Regeneron

@Regeneron

4 years

We’ve initiated a global clinical program w/ @Sanofi for people hospitalized with severe #COVID19 , testing our IL-6 receptor antibody. Read on:

2

72

113

Regeneron

@Regeneron

4 years

We're the only biopharma to be founded and led by physician-scientists for our entire 30+ year history. Meet our leaders:

8

20

108

Regeneron

@Regeneron

4 years

Thank you to all the doctors, scientists and others on the front lines who are working tirelessly to help those in need today, and every day. #NationalDoctorsDay

2

21

106

Regeneron

@Regeneron

6 years

We're at #EADV2018 w/ @SanofiGenzyme discussing the latest research in #atopicdermatitis care. While AD may be visible on the skin, its impact goes much further. It's a chronic immune disease with the potential for debilitating effects on quality of life.

3

22

102

Regeneron

@Regeneron

3 years

#ASCO21 will feature new research on advanced #BasalCellCarcinoma ( #BCC ). Which of the below would be most helpful to learn about?

Quality of life

349

Why pts discontinue Tx

211

1

11

101

Regeneron

@Regeneron

3 years

Following the EUA of our #antibody cocktail for #COVID19 , our Founder & CEO Len Schleifer reflects on how we got here and what’s still ahead for our team in a #RegeneronPerspectives blog.

Read Regeneron Perspectives

regeneron.com

7

20

98

Regeneron

@Regeneron

3 years

Reminder: Our investigational antibody cocktail for #COVID19 is FREE to patients who qualify under the Emergency Use Authorization parameters (just like the vaccines are)

34

38

103

Regeneron

@Regeneron

3 years

Get vaccinated! It is the best way to prevent #COVID19 . But also learn about treatments in case you need them:

30

36

97

Regeneron

@Regeneron

4 years

14) Thanks for reading, & for taking a minute to learn more about Regeneron beyond the memes! Here are a few other things – besides our COVID-19 efforts – that we were particularly proud of this year.

3

14

90

Regeneron

@Regeneron

2 years

Announcing additional positive results from our clinical trial evaluating a single dose of our investigational antibody cocktail to prevent #COVID19 in uninfected people over an 8-month period.

Read our new COVID-19 prevention data

regeneron.com

8

43

97

Regeneron

@Regeneron

7 years

It’s important for HCPs to listen to what their rheumatoid #arthritis patients have to say.

2

36

97

Regeneron

@Regeneron

6 years

Growing our genetics know-how: We’re thrilled to welcome Dr. Gonçalo Abecasis to the Regeneron #Genetics Center #qwRGC @gabecasis

22

38

97

Regeneron

@Regeneron

3 years

Congratulations @pfizer and @BioNTech_Group for shipping out the first doses of the #coronavirus vaccine across the U.S. We celebrate this important milestone in combating the pandemic, as we continue to work together on the safe development of treatments and vaccines.

1

7

88

Regeneron

@Regeneron

4 years

We shared our current timeline for COVID-19 drug discovery/development yesterday at #CowenHealthCare and the White House:

5

46

81

Regeneron

@Regeneron

4 years

At Regeneron, we are antibody pioneers. Our innovative technologies have accelerated and improved the traditional drug development process.

9

24

71

Regeneron

@Regeneron

4 years

#SoundOn 📣. It’s impossible to be still, especially when we have the power to transform lives. See how we go from #SciencetoMedicine .

Led by science. Driven by possibility.

regeneron.com

25

31

73

Regeneron

@Regeneron

2 years

We’re presenting information at #ASCO22 on the design of our clinical trial of investigational agents in patients with MET-overexpressing #NSCLC , a patient population in-need of therapeutic options. Read more about the trial in progress here:

Search ASCO Abstract TPS8593

asco.org

2

12

77

Regeneron

@Regeneron

3 years

At Regeneron, we’re fusing biological expertise and technological innovation with the goal of transforming the treatment of difficult-to-treat forms of #cancer . Watch the video to see our progress over the past 30 years. #ASH20

4

5

70

Regeneron

@Regeneron

7 years

Because of #atopicdermatitis , Holly can not do the things she enjoys. Watch her story. #UnderstandAD

2

22

60

Regeneron

@Regeneron

4 years

There’s an army working to battle #COVID19 . Thank you for staying home so our colleagues can keep working safely. #WorldHealthDay #ThanksHealthHeroes

2

14

73

Regeneron

@Regeneron

3 years

Our oncology researchers are exploring the potential of bispecific #antibodies to stretch the boundaries of the immunotherapy revolution. Read more in a recent #RegeneronPerspectives blog. #ASH20

regeneron.com

3

5

68

Regeneron

@Regeneron

4 years

We’ve treated the first ex-US severe #COVID19 patient in our global clinical program w/ @Sanofi with our IL-6 receptor antibody. Learn more:

1

26

68

Regeneron

@Regeneron

3 years

We're focused on exploring ways to help children with uncontrolled #asthma – a disease with a significant impact on everyday life. Learn more about asthma and type 2 inflammation:

8

14

67

Regeneron

@Regeneron

6 years

Announcing new consortium w/ top #lifescience orgs @pfizer @abbvie @Alnylam @AstraZeneca & @biogen to accelerate @uk_biobank #genetic sequencing (1/2) #JPM18

4

29

65

Regeneron

@Regeneron

4 years

We quickly determined a formula for VTM to meet NYS-specs & our colleagues volunteered to make/package it over weekends/late nights; 100K made so far, with 500K total to be delivered to NYS, a $1M in-kind donation of supplies & labor

4

9

66

Regeneron

@Regeneron

3 years

#COVID19 news: Our investigational antibody cocktail was shown in vitro to successfully neutralize #SARSCoV2 variants first identified in the UK and South Africa. @Columbia Read more:

6

22

66

Regeneron

@Regeneron

1 year

No attachment issues here. This Valentine’s Day, we’re admiring antibodies that bind tightly to the targets they love, even withstanding the variants that come their way. Check out our work in Ebola, which is the cover feature in Cell Host & Microbe. @cellhostmicrobe

Learn more

cell.com

7

6

68

Regeneron

@Regeneron

4 years

13) We’re a group of people working as hard as we possibly can to fight this terrible & disruptive disease. It’s been an unexpected & challenging year for us all, but we’re optimistic about what we can do by harnessing the power of science.

2

8

62

Regeneron

@Regeneron

3 years

Bispecific #antibody therapies have the potential to transform cancer treatment. Drs. Israel Lowy & Andres Sirulnik discuss how we’re stretching the boundaries of #immunotherapy innovation in our latest #RegeneronPerspectives blog.

Read Regeneron Perspectives

regeneron.com

2

3

60

Regeneron

@Regeneron

4 years

#DYK : anti-viral antibody medicines mimic the natural defenses and pathways of the immune system. Find out how they could serve as an important bridge to a vaccine:

Antibody medicines may be able to help people achieve immunity to the virus that causes COVID-19 -...

www.usatoday.com

25

26

55

Regeneron

@Regeneron

4 years

Congrats to the 2020 #RegeneronSTS top winner, Lillian Petersen, for her exceptional invention to predict crop yield! The future of #science is very bright thanks to Lillian and the other talented finalists. For more: CC: @Society4Science .🏅

0

14

64

Regeneron

@Regeneron

7 years

Working together is essential to advancing #raredisease research. Raising our hands w/ our collaborators for #RareDiseaseDay @RareDiseases

0

18

61

Regeneron

@Regeneron

4 years

We’re so proud – Regeneron is once again #1 on @sciencemagazine ’s annual survey of Top Biopharma Employers! Thanks to our inspiring team who are using #science to create a healthier future. #SCTopEmployer

4

6

64

Regeneron

@Regeneron

7 years

#Atopicdermatitis is not just skin deep. Learn how AD affects people personally and professionally. #AAD17 #AAAAI17

0

12

59

Regeneron

@Regeneron

3 years

Producing our #antibody medicines is a complex and time-intensive process. We break down how our #RegeneronIOPS team turns cells into life-changing medicines using the power of #science .

3

17

56

Regeneron

@Regeneron

7 years

Peter Moffat, award-winning screenwriter, has a personal history w/ severe #atopicdermatitis . #UnderstandAD

6

18

57

Regeneron

@Regeneron

3 years

We’re announcing the first clinical and virologic results for our investigational antibody cocktail in hospitalized patients with #COVID19 . Learn more:

1

28

62

Regeneron

@Regeneron

4 years

3) Our investigational antibody combination therapy (known as ‘REGN-COV2’) is currently being tested in clinical trials. It was invented this year using our proprietary technologies that were developed over the course of 30 years.

3

10

57

Regeneron

@Regeneron

5 years

A recent global study showed 82% of adults with #atopicdermatitis who are receiving immunosuppressants also have at least one other atopic condition. We're improving clinical understanding of these diseases to better inform how they may be treated. #WCD2019

1

11

57

Regeneron

@Regeneron

4 years

5) We did not use human stem cells or human embryonic stem cells in our COVID-19 program. Like many other science-focused organizations, we do use these tools in a responsible & limited manner for certain early research. More here:

4

22

57

Regeneron

@Regeneron

4 years

When you recover from an #infection , you are believed to acquire some lasting immunity against that disease through protective antibodies and immune system memory. More on the important role of adaptive immunity:

3

28

55

Regeneron

@Regeneron

6 years

What do dress-making, puzzles and #science have in common? Regeneron scientist Jean can tell you.

1

6

57

Regeneron

@Regeneron

7 years

George, #regeneronsts alumnus, #REGN Pres & CSO, takes a selfie w/ the finalists

2

24

59

Regeneron

@Regeneron

4 years

We’re announcing with @Society4Science our title sponsorship of the International Science and Engineering Fair, the world’s largest pre-college #science and #engineering competition. Find out more: #RegeneronISEF

2

26

62

Regeneron

@Regeneron

4 years

Our CSO George Yancopoulos discussed on @CNNi how we’re applying lessons from our #Ebola research to finding a potential medicine for #COVID19 . Watch via w/ @jchatterleyCNN

Julia Chatterley

@jchatterleyCNN

4 years

A #PassiveVaccine for #COVID19 ? What about a drug that might mean less ventilator use? Biotech giant @Regeneron is working on both. A fascinating convo with Dr. George Yancopolous CSO, on the science race to save lives. #CoronavirusOutbreak

9

42

140

3

23

57

Regeneron

@Regeneron

9 months

#BREAKING : The U.S. FDA has approved our treatment for wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. Learn more about the #FDAapproval and our ongoing commitment to those impacted by these #RetinalDiseases :